NIH Scientists Banned from Studying Human Fetal Tissue

External researchers funded by US federal grants can continue their experiments under tighter scrutiny.

kerry grens
| 2 min read
esc embryonic stem cell fetal tissue

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, DRA_SCHWARTZ

The US Department of Health and Human Services announced yesterday (June 5) that scientists at the National Institutes of Health will no longer be able to study human fetal tissue, although projects funded by the US government at external institutions can continue with increased ethical oversight.

An anonymous senior official in President Donald Trump’s administration tells the Associated Press that the decision was Trump’s. “Promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration,” HHS’s statement reads.

Anti–abortion rights advocates praised the move, while a number of scientists expressed disappointment.

“Prohibiting valuable research that uses fetal tissue that is otherwise going to be discarded doesn’t make any sense,” Lawrence Goldstein, a regenerative medicine specialist at the University of California, San Diego, tells the AP. “It blocks important future research vital to the development of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo